Previous 10 | Next 10 |
home / stock / medif / medif news
McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm Labs’ CBD25:, have received a No Objection Letter from Health Canada to begin recruiting human subjects for a placebo-control...
Received first instalment of a government grant for $330,000AUD as part of the Australian government’s Manufacturing Modernisation program aimed at supporting manufacturers scaling their businesses. Grant to be used for automation of downstream manufacturing and scaling purif...
Completed the regulatory process required to ship medical cannabis to Brazil with import permits issued from ANVISA and export permits issued from Health Canada. Initial deliveries will be under the compassionate care program. First shipments to Brazil to be used for patient trials to...
MediPharm Labs Corp. (MEDIF) Q2 2021 Earnings Conference Call August 13, 2021, 08:30 AM ET Company Participants Keith Strachan – President and Interim CEO Greg Hunter – Chief Financial Officer Chris Taves – Chairman Conference Call Participants Scott Fortune – ROTH...
BARRIE, Ontario, Aug. 16, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished dose pr...
TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished produc...
MediPharm Labs (MEDIF) has received a Drug Establishment Licence ((DEL)) issued by Health Canada in accordance with the Food and Drugs Act and Regulations. The DEL serves to confirm compliance to Good Manufacturing Practice ((GMP)) standards. The DEL is a first of its kind licence for cannabi...
Health Canada Drug Establishment Licence allows MediPharm Labs to conduct pharmaceutical manufacturing and sale of Active Pharmaceutical Ingredients and Pharmaceutical Drug Products Makes MediPharm Labs a full-service pharmaceutical company that can support the global pharma entry...
FN Media Group Presents USA News Group News Commentary Vancouver, BC – July 9, 2021 – USA News Group – As part of its recent cannabis M&A spree, HEXO Corp. (NYSE:HEXO) (TSX:HEXO) spent nearly another billion dollars, acquiring Ca...
Investing In Top Marijuana Stocks In The Summer Of 2021 Are top marijuana stocks on your investment radar for 2021? If so many of the best cannabis stocks to invest in have seen significant declines in the market for the past 4 months. Currently, this could be a good time to find th...
News, Short Squeeze, Breakout and More Instantly...
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders Canada NewsWire TORONTO , June 26, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical comp...
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols Canada NewsWire MediPharm has licenced global manufacturing, distribution, and sales rights of the novel advanced medical cannabis technology from Remidose Aerosols. Product...